NCT05910918 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Bagshaw SM, Webb SA, Delaney A, George C, Pilcher D, Hart GK, Bellomo R
Very old patients admitted to intensive care in Australia and New Zealand: a multi-centre cohort analysis. Crit Care. 2009;13(2):R45. doi: 10.1186/cc7768. Epub 2009 Apr 1.
Boumendil A, Somme D, Garrouste-Orgeas M, Guidet B
Should elderly patients be admitted to the intensive care unit? Intensive Care Med. 2007 Jul;33(7):1252. doi: 10.1007/s00134-007-0621-3. Epub 2007 Apr 3.
Laake JH, Dybwik K, Flaatten HK, Fonneland IL, Kvale R, Strand K
Impact of the post-World War II generation on intensive care needs in Norway. Acta Anaesthesiol Scand. 2010 Apr;54(4):479-84. doi: 10.1111/j.1399-6576.2009.02170.x. Epub 2009 Nov 23.
Nguyen YL, Angus DC, Boumendil A, Guidet B
The challenge of admitting the very elderly to intensive care. Ann Intensive Care. 2011 Aug 1;1(1):29. doi: 10.1186/2110-5820-1-29.

Effect of Intensive Care Nurses' Training Package on the Safety Culture of Critically Ill Geriatric Patients:Findings and Implications for Clinical Practice

Details for clinical trial NCT05910918

Clinical trial NCT05910918 - References